Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqCM - Delayed Quote USD

Basel Medical Group Ltd Ordinary Shares (BMGL)

Compare
4.2000
-0.0900
(-2.10%)
At close: 4:00:02 PM EST
4.1800
-0.02
(-0.48%)
After hours: 4:25:52 PM EST
Loading Chart for BMGL
DELL
  • Previous Close 4.2900
  • Open 4.2800
  • Bid 4.2000 x 100
  • Ask 4.2900 x 100
  • Day's Range 4.0000 - 4.3980
  • 52 Week Range 4.0000 - 5.4000
  • Volume 112,819
  • Avg. Volume 880,880
  • Market Cap (intraday) 77.511M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 52.50
  • EPS (TTM) 0.0800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.

baselmedical.com

32

Full Time Employees

June 30

Fiscal Year Ends

Recent News: BMGL

View More

Performance Overview: BMGL

Trailing total returns as of 3/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

BMGL
0.24%
S&P 500
1.76%

1-Year Return

BMGL
0.24%
S&P 500
12.61%

3-Year Return

BMGL
0.24%
S&P 500
33.48%

5-Year Return

BMGL
0.24%
S&P 500
84.60%

Compare To: BMGL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BMGL

View More

Valuation Measures

Annual
As of 3/3/2025
  • Market Cap

    77.51M

  • Enterprise Value

    79.24M

  • Trailing P/E

    50.47

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.41

  • Price/Book (mrq)

    13.83

  • Enterprise Value/Revenue

    10.64

  • Enterprise Value/EBITDA

    34.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.58%

  • Return on Assets (ttm)

    8.44%

  • Return on Equity (ttm)

    31.77%

  • Revenue (ttm)

    10.07M

  • Net Income Avi to Common (ttm)

    2.07M

  • Diluted EPS (ttm)

    0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.04M

  • Total Debt/Equity (mrq)

    75.55%

  • Levered Free Cash Flow (ttm)

    1.43M

Research Analysis: BMGL

View More

Company Insights: BMGL

Research Reports: BMGL

View More

People Also Watch